AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.3980
-0.0070 (-1.73%)
Apr 21, 2025, 4:00 PM EDT - Market closed
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $4.19 million as of April 21, 2025. Its market cap has decreased by -98.56% in one year.
Market Cap
4.19M
Enterprise Value
17.13M
1-Year Change
-98.56%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $4.19M, a decrease of -93.41%. That is a compound annual growth rate of -49.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 4.27M | -80.24% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |